neuroinflammation News
Latest articles and news about neuroinflammation on AXL Media.
Latest Articles
- Scripps Research Scientists Discover Molecular STING Switch Driving Chronic Neuroinflammation in Alzheimer’s Disease Patients
Published: Apr 25, 2026
Section: Medical News
Researchers at Scripps Research have identified a chemical modification of the STING protein, known as S-nitrosylation, that triggers harmful brain inflammation in Alzheimer’s dise...
- Boston Children's Researchers Find "Cancer-Like" Mutations in Brain Immune Cells May Be a Primary Driver of Alzheimer's
Published: Apr 22, 2026
Section: Health Technology
A groundbreaking study published in Cell suggests that Alzheimer’s disease may be driven by the same genetic mutations that cause blood cancers. Researchers at Boston Children’s Ho...
- Washington State University Study Finds Endometriosis Rewires Brain Pathways to Sustain Chronic Pain
Published: Apr 18, 2026
Section: Medical News
A groundbreaking study from Washington State University reveals that endometriosis is more than a localized gynecological condition, as repeated inflammatory cycles can permanently...
- Journal of Clinical Investigation Review Details Dual Role of Immune Signaling in Driving Neurodegenerative Decay
Published: Apr 18, 2026
Section: Medical News
A comprehensive review of central nervous system immunity reveals that the brain's defense mechanisms, including microglia and T cells, act as double-edged swords that can both mit...
- High-Dose Flu Vaccine Modestly Lowers Alzheimer’s Risk in Older Adults, Study Finds
Published: Apr 8, 2026
Section: Medical News
A large-scale observational study published in Neurology suggests that high-dose inactivated influenza vaccines (H-IIV) provide a greater protective effect against Alzheimer’s dise...
- UC Davis MIND Institute Identifies Immune System "Brakes" as Potential Therapy for Autism Inflammation
Published: Apr 3, 2026
Section: Medical News
New research from the UC Davis MIND Institute has revealed that regulatory T cells (Tregs), which function as the immune system's primary anti-inflammatory mechanism, are significa...
- UCSF Study Identifies DNA Breakdown in Gray Matter Neurons as Critical Driver of Multiple Sclerosis Progression
Published: Apr 2, 2026
Section: Health Technology
Researchers from UCSF, the University of Cambridge, and Cedars-Sinai have traced the loss of gray matter in multiple sclerosis to a specific mechanism of DNA damage in CUX2-express...
- Gut-Brain Axis Manipulation Shows Potential to Reverse Early Memory Loss Through Targeted Microbial Shifts
Published: Apr 1, 2026
Section: Medical News
New research published in Nutrition Research indicates that modifying the gut microbiome through diet and probiotics can significantly improve cognitive function in adults over 45....
- New Research Reveals APOE4 Gene Impacts Brain Immunity and Alzheimer's Risk with Striking Gender Differences
Published: Mar 30, 2026
Section: Science & Tech
A study published in the journal Neuron identifies that the APOE4 allele, the strongest genetic risk factor for Alzheimer’s, reshapes the brain's immune and lymphatic systems in fu...
- Keio University Study Identifies Gut Epithelium as the Primary Site for Priming Pathogenic T Cells in Multiple Sclerosis
Published: Mar 28, 2026
Section: Medical News
A landmark study published in Science Immunology reveals that intestinal epithelial cells initiate neuroinflammation by presenting antigens directly to immune cells. Researchers at...
- Keio University Researchers Identify Gut Epithelial Cells as Primary Initiators of Brain Inflammation in Multiple Sclerosis
Published: Mar 28, 2026
Section: Health
A landmark study published in Science Immunology has uncovered a specific cellular mechanism linking intestinal immunity to neurodegeneration in Multiple Sclerosis (MS). Researcher...
- Two Major Phase 3 Trials Confirm Oral Semaglutide Fails to Slow Cognitive Decline in Early Alzheimer’s Patients
Published: Mar 23, 2026
Section: Health
Results from the global "evoke" and "evoke+" clinical trials published in The Lancet show that oral semaglutide does not meaningfully delay the progression of early-stage Alzheimer...